VIJAYA DIAGNOSTICS LTD. IPO ANALYSIS

Vijaya Diagnostic Centre is one of the fastest-growing diagnostic chains in Southern India,Established in 1981. The company offers a one-stop solution for pathology and radiology testing services. The company offers around 740 routine tests, 870 specialized pathology tests, 220 basic tests, and 320 advanced radiology tests. The company also offers a broad spectrum of customized health and wellness packages to its customers.Company’s operational network consists of 80 diagnostic centers and 11 reference laboratories spread across 13 cities and towns in the states of Telangana, Andhra Pradesh, National Capital Region, and Kolkata. 96.2% of the revenue comes from Hyderabad, the rest of Telangana, and the Andhra Pradesh region. During the year ended March 31, 2021, the company conducted approximately 6.20 Mn pathology tests and 0.89 Mn radiology tests for approximately 2.63 Mn customers.Vijaya Diagnostic has Largest and fastest-growing diagnostic chain in Southern India.It is Affordable, one-stop solution diagnostics service provider with a focus on superior qualityalso having strong technical capabilities, cutting-edge diagnostic testing technology and robust IT infrastructure.As of March 31, 2021, all Vijaya Diagnostic Centre laboratories hold National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditations, and three diagnostic centers hold Patient Safety & Quality of Care (NABH) accreditations.For FY 21, the company had total assets of Rs 5409.40 million and a Revenue of Rs. 3885.93 million. Vijaya Diagnostic revenue has risen from 2019 to 2021. The company’s profit rose from 462.72 million in 2019 to 849.11 million in 2021. The Vijaya Diagnostic IPO open date is Sep 1, 2021, and the close date is Sep 3, 2021. The issue may list on Sep 14, 2021.The issue size of the IPO is supposed to be 1895.04 Cr., Considering the industry in which the company falls, it is suggestible to invest in Vijaya Diagnostic for medium to long term.